Mycotopia Therapies, Inc.
TPIA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $3 | $30 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $3 | $30 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$1 | -$2 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$1 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0 | -0.25 | -0.22 |
| % Growth | -139,900% | 100% | -13.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$0 |